BCL11B Peptide - C-terminal region

Aviva Systems Biology

BCL11B Peptide - C-terminal region

23

Western Blot

Research Use Only

Lyophilized powder

BCL11B

BCL11 transcription factor B

ATL1, ATL1-alpha, ATL1-beta, ATL1-delta, ATL1-gamma, CTIP-2, CTIP2, IDDFSTA, IMD49, RIT1, SMARCM2, ZNF856B, hRIT1-alpha, B-cell lymphoma/leukemia 11B, B cell CLL/lymphoma 11B, B-cell CLL/lymphoma 11B (zinc finger protein), B-cell CLL/lymphoma 11B/T-cell receptor delta constant region fusion protein, B-cell lymphoma/leukaemia 11B, BAF chromatin remodeling complex subunit BCL11B, BCL-11B, BCL11B, BAF complex component, BCL11B/TRDC fusion, COUP-TF-interacting protein 2, hRit1, radiation-induced tumor suppressor gene 1 protein, zinc finger protein hRit1 alpha

This is a synthetic peptide designed for use in combination with anti-BCL11B Antibody, made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

-20°C

41116100

Human